Minimal change disease

Patients should undergo routine testing for serum urea and creatinine, and urinalysis at least every 6 months. Those taking immunosuppressants and corticosteroids should be regularly evaluated for complications of treatment. This includes BP, weight, and growth monitoring at each visit to exclude hypertension, growth failure or significant weight gain, potential complications of repeated corticosteroid therapy. In addition, an FBC to evaluate for blood dyscrasias, and a complete metabolic panel to evaluate for liver function and electrolyte abnormalities, should be performed to exclude consequences of immunosuppressant therapy.